VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) -- BIGG Digital Assets Inc. (“BIGG” or the “Company”)(TSXV: BIGG; OTCQX: BBKCF; WKN: A2PS9W), a leading innovator in the digital assets space and owner of TerraZero, Netcoins and Blockchain Intelligence Group, is pleased to announce that TerraZero Technologies’ Intraverse is redefining what it means to be an artist in the digital age. Today, the company announces a new wave of music activations across its immersive platform—each a milestone not jus ...

BOCA RATON, FL, June 24, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the "Company") the first public company with a treasury strategy built to accumulate and compound Solana ("SOL"), today announced a strategic validator partnership with the dogwifhat (WIF) community, one of the most iconic and culturally significant memecoin ecosystems on Solana. Under this partnership, DeFi Dev Corp. will operate a dedicated dogwifhat validator node on the Solana blockchain. The validator will be owned ...

EMERYVILLE, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- National Mortgage Insurance Corporation (National MI), the primary operating subsidiary of NMI Holdings, Inc. (NASDAQ: NMIH), announced today it has received three prestigious company culture awards. National MI is proud to be recognized as a Great Place To Work® in 2025 and has also earned a “Decade of Great” distinction for garnering the honor ten consecutive years. Additionally, the company was ranked No. 22 among Fortune magazine’s Best Workplaces in ...

TORRANCE, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- Navitas Semiconductor (Nasdaq: NVTS), the industry leader in next-generation GaNFast™ gallium nitride (GaN) and GeneSiC™ silicon carbide (SiC) power semiconductors, has been awarded the ‘Outstanding Technical Collaboration Award’ from VREMT Energy, a subsidiary of Geely, which specializes in new energy vehicle power batteries, electric drive systems, charging systems and energy storage systems. VREMT and Navitas opened a joint R&D Laboratory to accelerate ...

Core Viewpoint - Quoin Pharmaceuticals has received Rare Pediatric Disease Designation from the FDA for its lead asset QRX003, aimed at treating Netherton Syndrome, a rare genetic disorder affecting children [1][3][4] Company Overview - Quoin Pharmaceuticals Ltd. is a late clinical-stage specialty pharmaceutical company focused on developing treatments for rare and orphan diseases, with a pipeline that includes four products targeting various conditions [5] Regulatory Designations - The FDA's Rare Pediatric Disease Designation for QRX003 highlights its potential as a therapeutic candidate for an underserved pediatric population, following the Orphan Drug Designation granted by the EMA in May 2025 [2][3] Clinical Development - The company is focused on completing pivotal clinical studies for QRX003 and advancing it towards a New Drug Application (NDA) as the first potential treatment for Netherton Syndrome [3][5] Disease Background - Netherton Syndrome is a rare genetic disorder affecting approximately 1 in 200,000 newborns, with symptoms that can lead to severe skin inflammation and a mortality rate in infancy estimated at 10 to 20 percent [4]

Regarding his appointment as Chairman of the Board, Mr. Monteparte commented: "I'm honored to join Premier Air Charter as Chairman of the Board. The company is uniquely positioned in a high-growth market, and I look forward to working closely with the leadership team to accelerate innovation, drive operational excellence, and unlock long-term value for our shareholders and customers. About Premier Air Charter Vincent Monteparte Named Premier's Chairman of the Board of Directors CARLSBAD, Calif., June 24, 20 ...

SCOTTSDALE, Ariz., June 24, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or the “Company”, “we”, or “our”), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug Administration (“FDA”) approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that the Company will join the small-cap Russell 2000® Index and the broad-market Russell 3000® Index, effective after t ...

"This transaction reflects our continued commitment to unlocking shareholder value through the strategic development and monetization of our subsidiaries," said Jason Grady, CEO of DSS, Inc. "We believe the combination of Impact's disruptive pipeline with Dr. Ashleys' global infrastructure and commercial expertise will establish a robust, scalable biopharmaceutical platform. It further validates our strategy of creating long- term value by preparing our key assets for public market growth." NEW YORK, June 2 ...

Seventh IP Enforcement Action Underscores Alpha Modus' Mission to Unlock Shareholder Value Through Strategic Patent Monetization CORNELIUS, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- Alpha Modus Ventures, LLC ("AMV"), a related party of Alpha Modus Holdings, Inc. (NASDAQ: AMOD, and the "Company") which entered into a patent monetization agreement with the Company in April, today announced that it has filed a federal lawsuit in the United States District Court for the Western District of Texas against Rackspace ...

VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) -- Miata Metals Corp. (CSE: MMET) (FSE: 8NQ) (OTCQB:MMETF) (“Miata” or the “Company”) is pleased to announce that it has begun its planned drill test of the Puma Target. This follows the successful completion of the latest five holes drilled at the Golden Hand Target, for which assays are pending (see Miata news release dated June 19, 2025). Featuring a high-quality data set that showcases evidence of a potentially rich gold system, the Puma Targe ...